My Special Aflac Duck(R) Is Doing What We Had Hoped For: It Helps Children Cope With Cancer

NORTHAMPTON, MA / ACCESSWIRE / May 13, 2024 / Originally published on Aflac Newsroom

Intuitively, and by watching a child's reaction, Aflac was confident that My Special Aflac Duck was effective in supporting children and families going though cancer treatment, but we could only say "anecdotally" - until now. Recent clinical research finds that our robotic duck helps pediatric cancer patients cope with distress and anxiety associated with treatments.

In the multi-year study, both parents and caregivers reported a reduction in distress, nausea, pain and treatment - and procedural anxiety - for their children who received My Special Aflac Duck, according to a clinical trial released April 5.

Research Team Includes (but not limited to):

• Dr. Ann Mertens - Research Director of the Cancer Survivor Program at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and Professor of Pediatrics at Emory University School of Medicine
  
• Dr. James Klosky - Director of Psychology and Neuropsychology at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and Professor of Pediatrics at Emory University School of Medicine
  
• Dr. Tamara Miller - Pediatric Hematologist/Oncologist at the Aflac Cancer and Blood Disorders Center of Children's Healthcare of Atlanta, and Associate Professor of Pediatrics at Emory University School of Medicine

Researchers at Children's Healthcare of Atlanta and Emory University School of Medicine conducted a randomized clinical trial utilizing My Special Aflac Duck. They surveyed 160 caregivers with children undergoing cancer treatment across eight hospitals throughout the United States over a three-year period. The team said they expected the duck to provide comfort to the pediatric cancer patients, but there is one finding that surprised them.

Questions researchers asked caregivers account for 18 symptoms of distress called the "global measure of parental distress" marking a holistic look at how helpful the duck could be for caregivers.

"Not only did initial observations yield statistically significant and positive results for the children in the My Special Aflac Duck group, but we also found that the duck benefitted caregivers such as parents and guardians," Klosky said. "This finding is notable because we utilized a global measure of parental distress in the study, suggesting that My Special Aflac Duck intervention resulted in significant symptom relief among those who care for young children on-treatment for cancer."

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 91,12$, was eine Steigerung von +5,00% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.

 

Morgan Stanley

 

Alle Partner

Übernehmen

Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche

WerbungDisclaimer